Albemarle Co. (NYSE:ALB – Get Free Report) has earned an average rating of “Hold” from the twenty-three analysts that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, fifteen have given a hold recommendation and seven have assigned a buy recommendation to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $117.60.
A number of equities analysts have recently commented on the company. Hsbc Global Res upgraded Albemarle to a “hold” rating in a report on Wednesday, July 17th. Oppenheimer cut their price target on shares of Albemarle from $188.00 to $178.00 and set an “outperform” rating on the stock in a report on Tuesday, July 9th. KeyCorp reduced their price target on shares of Albemarle from $151.00 to $132.00 and set an “overweight” rating on the stock in a research report on Monday, August 5th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Albemarle from $105.00 to $80.00 and set a “hold” rating for the company in a research report on Friday, August 16th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Albemarle from $115.00 to $78.00 and set a “neutral” rating on the stock in a report on Monday, August 19th.
Check Out Our Latest Stock Report on ALB
Institutional Trading of Albemarle
Albemarle Trading Down 3.7 %
Shares of ALB stock opened at $94.63 on Friday. The firm’s 50-day simple moving average is $89.32 and its 200-day simple moving average is $103.30. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.67 and a quick ratio of 1.75. Albemarle has a 1-year low of $71.97 and a 1-year high of $164.06. The firm has a market cap of $11.12 billion, a P/E ratio of 34.41, a PEG ratio of 13.81 and a beta of 1.54.
Albemarle (NYSE:ALB – Get Free Report) last posted its quarterly earnings results on Wednesday, July 31st. The specialty chemicals company reported $0.04 earnings per share for the quarter, missing analysts’ consensus estimates of $0.53 by ($0.49). Albemarle had a positive return on equity of 6.38% and a negative net margin of 6.72%. The company had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.34 billion. During the same period in the prior year, the business earned $7.33 EPS. The business’s revenue for the quarter was down 39.7% on a year-over-year basis. As a group, equities analysts forecast that Albemarle will post 0.46 EPS for the current year.
Albemarle Company Profile
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
Recommended Stories
- Five stocks we like better than Albemarle
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- Industrial Products Stocks Investing
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.